Sarah N Jasim, Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy
Sarah N Jasim1,4*, Amoura M. Abou-El-Naga1, Saad S Al-Dujaily2, Ahmed Badawy3
1Zoology Department, Mansoura University, Eygpt.
2High Institute for Infertility Diagnosis and ART, Al-Nahrain University, Iraq.
3College of Medicine, Mansoura University, Egypt.
4The University of Mashreq, Baghdad, Iraq.
Volume - 16,
Issue - 10,
Year - 2023
Polycystic ovarian syndrome (PCOS) is a prevalent and complex endocrine condition that affects 5 to 20% of reproductive-age women and is a leading cause of hirsutism and infertility. Selected 28 women were intentionally divided, according to the cause of infertility, into 14 infertile women with the polycystic ovarian syndrome (PCOS) and 14 non-polycystic ovarian syndromes (Male factor) used as a control group. For each patient, measurement of the fold of expression of Activin A, and Fibrillin-3 hormones, in blood was done on: On the day of the ovum collection and after 14 days of the embryo transfer (ET). The fold of activin an expression in pregnant groups was high compared to the Non-pregnant group for both PCOS and Non-PCOS women on the day of ova pick up while the fold of gene expression in the pregnant group was slightly more compared with the non-pregnant group for non-PCOS women, where the fold of gene expression in pregnant women decreased by compared with non –pregnant for PCOS women. The fold of fibrillin-3 expression in pregnant groups was high compared to the Non-pregnant group for both PCOS and Non-PCOS women, where the fold of gene expression was (0.86,0.84 ) for Non- PCOS, PCOS women respectively, which refers to an increase in FBN-3expression in the pregnant group compared to gene expression in Non-pregnant group.
Cite this article:
Sarah N Jasim, Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy. Study the Genetic Expression of Activin A and Fibrillin-3 in PCOS and Non-PCOS women. Research Journal of Pharmacy and Technology 2023; 16(10):4891-6. doi: 10.52711/0974-360X.2023.00793
Sarah N Jasim, Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy. Study the Genetic Expression of Activin A and Fibrillin-3 in PCOS and Non-PCOS women. Research Journal of Pharmacy and Technology 2023; 16(10):4891-6. doi: 10.52711/0974-360X.2023.00793 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-10-63
1. Implantation stages. Human Embryology. Online course in embryology for medicine students developed by the universities of Fribourg, Lausanne and Bern (Switzerland) with the support of the Swiss Virtual Campus. Retrieved 6 December, 2011.
2. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2: 16057.2.
3. Anuchithra Radhakrishnan S. Polycystic Ovarian Syndrome (PCOS) in Adolescence. Asian J. Nur. Edu. and Research 2012; 2(2): 55-64.
4. Asha K Varughese, Veena Greetta Tauro. Polycystic Ovarian Syndrome – An Overview. Int. J. Nur. Edu. and Research. 2019; 7(4): 601-604.
5. Veena Kirthika. S, Himabindu Daggumati, Padmanabhan. K, Jibi Paul, Selvaraj Sudhakar, Senthil Selvam. P. Effect of Structured Awareness Programme on Polycystic Ovarian Syndrome (PCOS) among Adolescent Girls. Research J. Pharm. and Tech. 2019; 12(12): 6097-6100.
6. Savita Vashist, Lavanya Nandan, Jony Sharma. A Study to Evaluate the effectiveness of Structured Teaching Programme on knowledge regarding of Polycystic Ovarian Syndrome among School teachers of selected school of Ghaziabad. Int. J. Nur. Edu. and Research. 2020; 8(2):195-201.
7. Asha K Varughese, Veena Greetta Tauro. Effectiveness of Structured Teaching Programme (STP) on Knowledge regarding Polycystic Ovarian Syndrome (PCOS) among Adolescent Girls, Kollam. Int. J. Nur. Edu. and Research. 2018; 6(4):360-362.
8. Neha Parmar, Munshi Ruzda Khanam, Patel Moshmi, Panchal Shruti, Goyara Krishna, Christian Brinky, Ninama Nidhi. A Study to assess The Effectiveness of Planned Teaching Programme on knowledge regarding Polycystic Ovarian Syndrome among Adolescent Girls in Selected Colleges at Nadiad City, Gujarat State. Int. J. of Advances in Nur. Management. 2019; 7(1):06-08.
9. Choragudi Srujana, Rayapu Vasundhara, Jonnalagadda Miryani. A Study To Assess The Knowledge Of Nursing College Students Regarding Polycystic Ovarian Syndrome In Selected College At Guntur District, Andhra Pradesh. Int. J. of Advances in Nur. Management. 2018; 6(3): 210-214.
10. Anitharajendrababu, Mini Abraham. Effectiveness of Planned Teaching Programme regarding Polycystic Ovarian Disease among Adolescent Girls. Int. J. Adv. Nur. Management. 2017; 5(2):143-145.
11. Santhipriya Monterio, Anusree G, Anusree. K. T, Arya Prasad N. T, RojaTom, Leethu David, Rasheeda Gopal, et. al. A Study to assess the effectiveness of Structured Teaching Programme regarding knowledge on Polycystic ovarian syndrome among the adolescents of selected PU College in Mangaluru. Asian J. Nursing Education and Research. 2021; 11(2):213-216.
12. Haneen Subhee Shaheed, Suzan Yousif Jasim, Wassan Abdul-Kareem Abbass. Studying Some Novel Biochemical and Immunological Markers in a Sample of Iraqi Women with Polycystic Ovarian Syndrome. Research J. Pharm. and Tech. 2020; 13(7): 3171-3178.
13. Fortin J, Boehm U, Deng C-X, Treier M, Bernard DJ. Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2. The FASEB Journal. 2014; 28(8):3396-3410.
14. Shaw ND, Histed SN, Srouji SS, Yang J, Lee H, Hall JE. Estrogen Negative Feedback on Gonadotropin Secretion: Evidence for a Direct Pituitary Effect in Women. The Journal of Clinical Endocrinology and Metabolism. 2010; 95(4):1955-1961.
15. Rozario T. and De Simone DW, et al. The extracellular matrix in development and morphogenesis: a dynamic view.Dev.Biol. 2010; 341:126-140.
16. Ramirez F, Sakai LY. Biogenesis and function of fibrillin assemblies. Cell Tissue Res. 2010; 339:71-82.
17. Fatemi HM, Polyzos NP, Van Vaerenbergh I, et al. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2013; 100:742-7.
18. Wu TC, Jih MH, Wang L and Wan YJ Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. Molecular Reproduction and Development. 1994; 38: 9–15.
19. Zhao J, Taverne MA, van der Weijden GC, Bevers MM and van den Hurk R. Effect of activin A on in vitro development of rat preantral follicles and localisation of activin A and activin receptor II. Biology of Reproduction. 2001; 65: 967–977.
20. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH and Mason AJ Effect of recombinant activin on androgen synthesis in cultured human thecal cells. Journal of Clinical Endocrinology and Metabolism. 1991; 72: 1206–1211.
21. Campbell BK and Baird DT Inhibin A is a follicle stimulating hormone-responsive marker of granulosa cell differentiation, which has both autocrine and paracrine actions in sheep. Journal of Endocrinology 2001; 169: 333–345.
22. Findlay JK An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biology of Reproduction 1993; 48: 15–23.
23. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM and Ethier JF Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily. Molecular and Cellular Endocrinology 2002; 191: 35–43.
24. Silva CC and Knight PG Modulatory actions of activin-A and follistatin on the developmental competence of in vitro-matured bovine oocytes. Biology of Reproduction 1998; 58: 558–565.
25. Alak BM, Coskun S, Friedman CI, Kennard EA, Kim MH and Seifer DB Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertility and Sterility 1998; 70: 1126–1130.
26. Teede H, Ng S, Hedger M, Moran L. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers. Metabolism. 2013; 62(10):1394-400.
27. O’Connor AE, McFarlane JR, Hayward S. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study.Human Reproduction. 1999; 14: 827–832.
28. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Human Reproduction Update. 2011; 17(1): 17-33.
29. Lockwood GM, Muttukrishna S and Ledger W. Inhibins and activins in human ovulation,conception and pregnancy.Hum Reprod Update. 1998; 4 (3): 284-295.
30. Al-Dujaily SS, Mohammed W. Role of fibrillin-3 in fertilization capacity in women undergoing intrauterine insemination. IJEIR. 2014; 6(2):34-39.
31. Diana Jordan C., Sandra D. Bohling, Noe L. Charbonneau, Lynn Y. Sakai First Fibrillins in Adult Human Ovary and Polycystic Ovary Syndrome: Is Fibrillin-3 Affected in PCOS? Research Article Find in PubMed. 2010; https://doi.org/10.1369/jhc.2010.956615